Large-scale Analysis Finds GLP-1 Agents Do Not Increase Risk of Pancreatic Cancer: New Study

Large-scale Analysis Finds GLP-1 Agents Do Not Increase Risk of Pancreatic Cancer: New Study

Concerns have been raised that the use of glucagon-like peptide-1 receptor agonists (GLP-1) may increase the incidence of pancreatitis or pancreatic cancer, but a large-scale cohort analysis found that this was unfounded. The results of a study on the risk association of pancreatic cancer with the use of GLP-1 agents conducted by Dr. Rachel Dankner … Read more

First clinical trial comparing implantable defibrillator + drug vs. drug alone

First clinical trial comparing implantable defibrillator + drug vs. drug alone

A clinical trial comparing the effectiveness of implantable cardioverter-defibrillator (ICD) implants versus medications in myocardial infarction survivors with heart failure has enrolled the first patient. The PROFID EHRA clinical trial began with the goal of recruiting 3,595 patients in 13 countries. Interest in this clinical trial is focused on the fact that it has been … Read more

Apixaban is better than aspirin in preventing stroke in patients with atrial fibrillation.

Apixaban is better than aspirin in preventing stroke in patients with atrial fibrillation.

A study showed that apixaban is more effective than aspirin for preventing stroke in patients with atrial fibrillation. The results of a clinical trial on apixaban for the prevention of stroke in patients with asymptomatic atrial fibrillation, conducted by researchers including Jeff S. Healy of the Population Health Research Center at McMaster University in Canada, … Read more

The Importance of Hyperacute Treatment for Stroke Prognosis on World Stroke Day

The Importance of Hyperacute Treatment for Stroke Prognosis on World Stroke Day

In celebration of World Stroke Day on October 29, the Korean Stroke Association (Chairman Eung-gyu Kim, Inje University College of Medicine, and Chairman Hee-jun Bae, Seoul National University College of Medicine) emphasized that receiving hyperacute treatment as quickly as possible within the golden time is directly related to stroke prognosis. Every year, October 29th is … Read more

Obesity Surgery Significantly Lowers Risk of Cardiovascular Disease and Blood Cancer: Research Results

Obesity Surgery Significantly Lowers Risk of Cardiovascular Disease and Blood Cancer: Research Results

The academic world is paying attention to research results showing that obesity surgery significantly lowers the risk of cardiovascular disease and blood cancer. Just by correcting the workload, not only the risk of blood cancer but also the mortality rate can be lowered. Accordingly, experts believe that more attention should be paid to preventive measures … Read more

The American Heart Association Refutes Claims of Cognitive Dysfunction from Active LDL-C Reduction

The American Heart Association Refutes Claims of Cognitive Dysfunction from Active LDL-C Reduction

The American Heart Association (AHA) issued a statement urging people to participate in efforts to lower low-density cholesterol (LDL-C) levels. Although it is common knowledge in the medical community that the lower LDL-C is, the better, this is a rebuttal to the fact that aggressive cholesterol lowering led to negative research results in some studies. … Read more

Alcoholic hepatitis G-CSF, which did not respond to steroids, was effective

A new study has found that adding granulocyte colony stimulating factor (G-CSF) to steroids in the treatment of severe alcoholic hepatitis could improve a patient’s 90-day survival rate. The results of a study examining the effects of co-administration of steroids and G-CSF were announced on the 6th at the AASLD Annual Meeting 2022. In patients … Read more

When rheumatoid patients are vaccinated against influenza, it is only necessary to stop MTX for 1 week

Although patients with rheumatoid arthritis stop taking methotrexate (MTX) for two weeks when vaccinated with flu shots, one study found that basically the same effect can be achieved even if it is stopped for a week. Currently, standard therapy is to stop the drug for 2 weeks, but it is not necessary to do so. … Read more

Ivermectin has no effect on patients with mild COVID-19

The result of a study showed that administering ivermectin to mild to moderate COVID-19 patients had no effect on the shortening of symptom duration. The results of a study on the effects of ivermectin administration on outpatients with COVID-19 conducted by researchers such as Susanna Naggie of Duke University of North Carolina, USA, were published … Read more